These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6763893)
1. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics. Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893 [TBL] [Abstract][Full Text] [Related]
2. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186 [TBL] [Abstract][Full Text] [Related]
3. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus. Mustonen A; Knip M; Akerblom HK Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771 [TBL] [Abstract][Full Text] [Related]
5. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Bottazzo GF; Dean BM; Gorsuch AN; Cudworth AG; Doniach D Lancet; 1980 Mar; 1(8170):668-72. PubMed ID: 6103089 [TBL] [Abstract][Full Text] [Related]
6. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
7. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration]. Majkowska L Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of various types of islet cell antibodies in diabetes as a function of its cause and duration]. Vialettes B; Di Campo-Rougerie C; Lassmann V; Vague P Presse Med; 1983 Oct; 12(37):2303-6. PubMed ID: 6226978 [TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic islet cell antibodies in type I diabetics in Israel and their first-degree relatives. Assa S; Karp M; Erster B; Laron Z Isr J Med Sci; 1985 Sep; 21(9):727-30. PubMed ID: 3902719 [TBL] [Abstract][Full Text] [Related]
10. Islet cell antibodies and diabetes in Nigerians. Oli JM; Bottazzo GF; Doniach D Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394 [TBL] [Abstract][Full Text] [Related]
11. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1]. Majkowska L; Czekalski S; Skwira J Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656 [TBL] [Abstract][Full Text] [Related]
12. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336 [TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes. Sensi M; Zuccarini O; Spencer KM; Beales P; Pujol-Borrell R; Pozzilli P Diabetes Res; 1985 Jan; 2(1):1-4. PubMed ID: 3888494 [TBL] [Abstract][Full Text] [Related]
14. [Islet cell antibodies in diabetes mellitus (author's transl)]. Pujol-Borrell R; Richart C Med Clin (Barc); 1980 Mar; 74(5):163-9. PubMed ID: 6991837 [TBL] [Abstract][Full Text] [Related]
15. Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality. Millward A; Hussain MJ; Peakman M; Pyke DA; Leslie RD; Vergani D Clin Exp Immunol; 1988 Feb; 71(2):353-6. PubMed ID: 3127094 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344 [TBL] [Abstract][Full Text] [Related]
18. Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus. Brown FM; Vinik AI; Ganda OP; Adri MN; Rabinowe SL Horm Metab Res; 1989 Aug; 21(8):434-7. PubMed ID: 2676819 [TBL] [Abstract][Full Text] [Related]
19. Islet-cell antibodies in IDDM and NIDDM in a Japanese population. Kobayashi T; Sawano S; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S Tohoku J Exp Med; 1983 Dec; 141 Suppl():271-4. PubMed ID: 6393435 [TBL] [Abstract][Full Text] [Related]
20. A population survey of pancreatic islet cell antibodies and antithyroid antibodies. Notsu K; Goto Y; Sakurami T; Note S; Nabeya N; Kuno S Tohoku J Exp Med; 1983 Dec; 141 Suppl():261-3. PubMed ID: 6393433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]